Article
Antidepressant agents and suicide death among US Department of Veterans Affairs patients in depression treatment.
Department of Veterans Affairs, Ann Arbor Center of Excellence (COE), Ann Arbor, MI, USA.
Journal of clinical psychopharmacology (impact factor:
5.09).
04/2012;
32(3):346-53.
DOI:10.1097/JCP.0b013e3182539f11
pp.346-53
Source: PubMed
- Citations (1)
-
Cited In (0)
-
Article: Problems due to medication costs among VA and non-VA patients with chronic illnesses.
[show abstract] [hide abstract]
ABSTRACT: To compare rates of cost-related medication underuse and other problems due to medication costs among Department of Veterans Affairs (VA) patients with rates among patients with Medicaid, private health insurance, Medicare, and no insurance coverage. Nationwide survey. A total of 4055 chronically ill patients completed an online questionnaire regarding cost-related adherence problems for medications used to treat 16 chronic illnesses. Respondents also reported whether they cut back on necessities due to medication costs, increased their debt burden to pay for prescriptions, and worried about how they would pay for their medications. Results: Rates of cost-related medication underuse were lower among VA patients (12%) than among patients with Medicaid (25%; P =.0004), Medicare (22%; P =.001), or no insurance (35%; P < .0001). In multivariate analyses, patients with Medicare or no insurance coverage were more likely than VA patients to forego medication at least once per month due to cost (adjusted odds ratios of 3.4 and 3.9; both P < or = .001). Patients with Medicare or no insurance coverage also were more likely than VA patients to forego basic needs to pay medication costs, borrow money to pay for their treatments, and worry frequently about how they would pay for their medication. The VA's prescription benefits may prevent problems due to medication costs. Studies assessing the impact of VA prescription coverage on health outcomes and service use will be needed to evaluate the cost-effectiveness of VA drug benefit policies.The American journal of managed care 12/2004; 10(11 Pt 2):861-8. · 2.46 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
address potential selection biases
antidepressant agents
Conventional Cox regression models
depression treatment
Drug Administration meta-analysis
examine suicide deaths
instrumental variable analyses
interpreting results
large sample sizes
lower risks
marginal structural models
Multiple analytic strategies
multiple Cox models
national sample
propensity-stratified Cox models
September 30
Studies report mixed findings
suicide death
suicide risks
Veterans Affairs patients